Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer
暂无分享,去创建一个
S. Ikeda | S. Kimura | Hideaki Nakamura | K. Kai | E. Sueoka | Yuki Kurihara | N. Sueoka-Aragane | Yohei Harada | A. Sato | Tomomi Nakamura | S. Kitamura | Y. Kurihara | Keita Kai